305 related articles for article (PubMed ID: 23533197)
21. Smurf1 inhibits mesenchymal stem cell proliferation and differentiation into osteoblasts through JunB degradation.
Zhao L; Huang J; Guo R; Wang Y; Chen D; Xing L
J Bone Miner Res; 2010 Jun; 25(6):1246-56. PubMed ID: 20200942
[TBL] [Abstract][Full Text] [Related]
22. Methylsulfonylmethane enhances BMP‑2‑induced osteoblast differentiation in mesenchymal stem cells.
Kim DN; Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Cho KH; Park KD; Lee HK; Yang YM
Mol Med Rep; 2016 Jul; 14(1):460-6. PubMed ID: 27175741
[TBL] [Abstract][Full Text] [Related]
23. Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation.
Bae JS; Gutierrez S; Narla R; Pratap J; Devados R; van Wijnen AJ; Stein JL; Stein GS; Lian JB; Javed A
J Cell Biochem; 2007 Feb; 100(2):434-49. PubMed ID: 16927309
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-338-3p regulates osteogenic differentiation of mouse bone marrow stromal stem cells by targeting Runx2 and Fgfr2.
Liu H; Sun Q; Wan C; Li L; Zhang L; Chen Z
J Cell Physiol; 2014 Oct; 229(10):1494-502. PubMed ID: 24648262
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway.
Sonomoto K; Yamaoka K; Oshita K; Fukuyo S; Zhang X; Nakano K; Okada Y; Tanaka Y
Arthritis Rheum; 2012 Oct; 64(10):3355-63. PubMed ID: 22674197
[TBL] [Abstract][Full Text] [Related]
26. The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation.
Liu Y; Bhat RA; Seestaller-Wehr LM; Fukayama S; Mangine A; Moran RA; Komm BS; Bodine PV; Billiard J
Mol Endocrinol; 2007 Feb; 21(2):376-87. PubMed ID: 17095577
[TBL] [Abstract][Full Text] [Related]
27. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
28. The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b.
Brun J; Fromigué O; Dieudonné FX; Marty C; Chen J; Dahan J; Wei Y; Marie PJ
Bone; 2013 Mar; 53(1):6-12. PubMed ID: 23201222
[TBL] [Abstract][Full Text] [Related]
29. Gliotoxin potentiates osteoblast differentiation by inhibiting nuclear factor-κB signaling.
Wang G; Zhang X; Yu B; Ren K
Mol Med Rep; 2015 Jul; 12(1):877-84. PubMed ID: 25816130
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin E3 ligase Wwp1 negatively regulates osteoblast function by inhibiting osteoblast differentiation and migration.
Shu L; Zhang H; Boyce BF; Xing L
J Bone Miner Res; 2013 Sep; 28(9):1925-35. PubMed ID: 23553732
[TBL] [Abstract][Full Text] [Related]
31. Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes.
Biver G; Wang N; Gartland A; Orriss I; Arnett TR; Boeynaems JM; Robaye B
Stem Cells; 2013 Dec; 31(12):2747-58. PubMed ID: 23629754
[TBL] [Abstract][Full Text] [Related]
32. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
[TBL] [Abstract][Full Text] [Related]
33. Cbl-b and c-Cbl negatively regulate osteoblast differentiation by enhancing ubiquitination and degradation of Osterix.
Choi YH; Han Y; Lee SH; Jin YH; Bahn M; Hur KC; Yeo CY; Lee KY
Bone; 2015 Jun; 75():201-9. PubMed ID: 25744063
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells.
Koch H; Jadlowiec JA; Campbell PG
Stem Cells Dev; 2005 Dec; 14(6):621-31. PubMed ID: 16433617
[TBL] [Abstract][Full Text] [Related]
35. Identification of C-terminal Hsp70-interacting protein as a mediator of tumour necrosis factor action in osteoblast differentiation by targeting osterix for degradation.
Xie J; Gu J
J Cell Mol Med; 2015 Aug; 19(8):1814-24. PubMed ID: 25818514
[TBL] [Abstract][Full Text] [Related]
36. Small nuclear ribonucleoprotein polypeptide N (Sm51) promotes osteogenic differentiation of bone marrow mesenchymal stem cells by regulating Runx2.
Meng F; Xu L; Huang S; Liu Y; Hou Y; Wang K; Jiang X; Li G
Cell Tissue Res; 2016 Oct; 366(1):155-62. PubMed ID: 27184949
[TBL] [Abstract][Full Text] [Related]
37. Effect of lamin A/C knockdown on osteoblast differentiation and function.
Akter R; Rivas D; Geneau G; Drissi H; Duque G
J Bone Miner Res; 2009 Feb; 24(2):283-93. PubMed ID: 18847334
[TBL] [Abstract][Full Text] [Related]
38. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway.
Li H; Li T; Fan J; Li T; Fan L; Wang S; Weng X; Han Q; Zhao RC
Cell Death Differ; 2015 Dec; 22(12):1935-45. PubMed ID: 26206089
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid-induced Smad3 expression is required for the induction of osteoblastogenesis of mesenchymal stem cells.
Dingwall M; Marchildon F; Gunanayagam A; Louis CS; Wiper-Bergeron N
Differentiation; 2011 Sep; 82(2):57-65. PubMed ID: 21612856
[TBL] [Abstract][Full Text] [Related]
40. Cbl-b enhances Runx2 protein stability and augments osteocalcin promoter activity in osteoblastic cell lines.
Salingcarnboriboon RA; Pavasant P; Noda M
J Cell Physiol; 2010 Sep; 224(3):743-7. PubMed ID: 20578243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
